Classifying ADRs--does dose matter?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses.The journal of allergy and clinical immunology. In practice · 2024
   Article
2. How to manage drug-virus interplay underlying skin eruptions in children.The World Allergy Organization journal · 2024
   Review
3. Tools for Etiologic Diagnosis of Drug-Induced Allergic Conditions.International journal of molecular sciences · 2023
   Review
4. Pharmacometric modeling of drug adverse effects: an application of mixture models in schizophrenia spectrum disorder patients treated with clozapine.Journal of pharmacokinetics and pharmacodynamics · 2023
   Article
5. Toxic Epidermal Necrolysis and Stevens - Johnson Syndrome Following Sintilimab Administration in a Non-Small Cell Lung Cancer Patient: A Case Report.Journal of inflammation research · 2023
   Article
6. Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health.Human genetics · 2022
   Review
7. An Updated Review of the Diagnostic Methods in Delayed Drug Hypersensitivity.Frontiers in pharmacology · 2020
   Review
8. New Insights in Computational Methods for Pharmacovigilance:International journal of environmental research and public health · 2019
   Article
9. Antibiotic allergy labels in hospitalized and critically ill adults: A review of current impacts of inaccurate labelling.British journal of clinical pharmacology · 2019
   Review
10. Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations.Pharmaceutical research · 2018
    Review
11. Antibiotic Allergy in Pediatrics.Pediatrics · 2018
    Review
12. [Acute hypersensitivity reactions associated with monoclonal antibodies for targeted therapy].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2018
    Review
13. Pharmacogenomics of off-target adverse drug reactions.British journal of clinical pharmacology · 2017
    Review
14. Classifying ADRs--does dose matter?British journal of clinical pharmacology · 2016
    Article
15. A web resource for mining HLA associations with adverse drug reactions: HLA-ADR.Database : the journal of biological databases and curation · 2016
    Article
16. The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centre.BMC infectious diseases · 2015
    Article
17. Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.The journal of allergy and clinical immunology. In practice
    Review
18. The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.The journal of allergy and clinical immunology. In practice
    Review

Corrections and comments

• Comment on
  The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactions.2016

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as